Open Heart

NOVEMBER 9, 2024

Objective To evaluate the impact of intraoperative neuromonitoring (IONM) on stroke and operative mortality after coronary and/or valvular operations. Propensity-score matching was employed to assess the association of IONM usage with operative mortality and stroke. vs 2.5%) and stroke (4.9% for stroke. for stroke.

Cerebrovascular Disease 52

Cerebrovascular Disease Stroke Strokes Biomarkers 52

Journal of Cardiovascular Pharmacology

AUGUST 1, 2024

Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. In this paper, we comment the findings reported by Liu et al.

Cerebrovascular Disease 40

Cerebrovascular Disease Myocardial Infarction Thrombosis Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP280-ATP280, February 1, 2024. As access and coverage of genetic testing has increased, it is being used more commonly in adults with strokes. Indications for testing included evaluation of carotid and vertebral dissections, recurrent stroke, cryptogenic stroke, and leukoencephalopathy.

Stroke 40

Stroke Strokes Cerebrovascular Disease Outpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP102-ATMP102, February 1, 2024. Introduction:Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established.Methods:Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP271-ATP271, February 1, 2024. Introduction:Despite significant efforts to increase public awareness of cerebrovascular disease, the incidence of stroke and transient ischemic attack (TIA) in young adults has remained elevated, representing a major public health concern.

Stroke 40

Stroke Strokes Cerebrovascular Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP291-ATP291, February 1, 2024. Since endothelial dysfunction is implicated in stroke pathogenesis and is featured with suppressed endothelial nitric oxide (NO) synthase (eNOS) and NO deficiency, restoring endothelial NO represents a promising approach to treating stroke injury.

Stroke 40

Stroke Strokes Cerebrovascular Disease Innovation 40

Stroke Journal

JANUARY 18, 2024

Stroke, Ahead of Print. Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias.

Dementia 90

Dementia Cerebrovascular Disease Biomarkers Stroke 90

Stroke Journal

OCTOBER 10, 2023

Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. The primary outcome was incident acute ischemic stroke.

Kidney Disease 40

Kidney Disease Stroke Strokes Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP66-AWP66, February 1, 2024. Background:With the advent of endovascular therapy as a treatment modality for LVO stroke, the importance of stroke networks has become increasingly clear. ICD10 Codes I60-I69 were used to indicate cerebrovascular disease.

Cerebrovascular Disease 40

Cerebrovascular Disease Hospital Stroke Strokes 40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Results CV event rates among patients treated with statins who have established CV disease, including coronary artery disease, cerebrovascular disease, or peripheral arterial disease, accumulate over time, with a cumulative incidence of CV events reaching up to approximately 40% over 10 years.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease 64

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionStroke is the most common manifestation of cerebrovascular disease, which requires prompt diagnosis and treatment. To reduce the rising death and disability due to stroke in Africa, adequate vascular neurology services are crucial.

Cerebrovascular Disease 40

Cerebrovascular Disease Dementia Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. In our cohort 7.2%

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL). 3.17, P  = 0.006). Occurrence of acute CAD was higher in H-Lpa men (HR 3.1,

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Coronary Artery Disease 45

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2024. Introduction:Moyamoya disease (MMD) is a rare cerebrovascular disease that can lead to stroke.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Circulation Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A18-A18, February 1, 2024. In patients with preexisting cerebrovascular disease, pollution exposure can compound underlying pathology and may accelerate functional decline. Background:Exposure to ambient air pollution causes neuroinflammation and white matter (WM) damage.

Cerebrovascular Disease 40

Cerebrovascular Disease Stenosis Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The patient was diagnosed with ACA territory stroke complicated by PH2‐type hemorrhagic conversion. She improved clinically and was discharged to rehab with a diagnosis of recurrent hemorrhage attributed to anticoagulant use and recent stroke.

Hemorrhage 40

Hemorrhage AFIB Cerebrovascular Disease Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. He was started on secondary stroke prevention and referred to vascular surgery for evaluation of revascularization. Duplex US revealed 80‐99% stenosis of both right and left proximal internal carotid arteries.

Stenosis 40

Stenosis Cerebrovascular Disease Diabetes Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionInterventional Neurology (IN) is a rapidly expanding field, with new devices and techniques broadening the range of cerebrovascular diseases that can be treated (1).

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Education Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.

Arterioles 40

Arterioles Cerebrovascular Disease Outpatient Document 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

DAIC

JANUARY 22, 2024

The International Stroke Conference 2024 will be held Feb. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

Stroke 100

Stroke Strokes Hospital Thrombolysis 100

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP289-AWP289, February 1, 2024. Introduction:Blunted night-to-day blood pressure (BP) dipping was common in ischemic cerebrovascular disease (ICVD). BP dipping could be influenced by baroreflex, which stabilized BP by regulating sympathovagal balance.

Blood Pressure 40

Blood Pressure Cerebrovascular Disease Risk Factors Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A91-A91, February 1, 2024. Background:Patients with stroke frequently suffer from post-stroke mood disturbances (PSMD) which decrease their quality of life. It remains unclear whether the prevalence of PSMD differs according to stroke subtype. at 90 days were collected.

Hemorrhage 40

Hemorrhage Stroke Strokes Cerebrovascular Disease 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP248-ATP248, February 1, 2024. Background:Diabetes is a highly heritable stroke risk factor with numerous known genetic risk variants. However, the role of these genetic risk variants in the development of cerebrovascular disease in Native Hawaiians remains unknown. 2.05; p=0.04).Conclusions:Among

Genetic predisposition 40

Genetic predisposition Diabetes Stroke Strokes 40

Cardiomatics

AUGUST 4, 2022

Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease. In Poland, this problem looks similar: the main cause of death are cardiovascular diseases.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Cerebrovascular Disease 52

Circulation

NOVEMBER 11, 2024

They increase the risk of hypertension, coronary artery disease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiac arrest, and stroke. Introduction:Cocaine and methamphetamine, stimulants with potent central nervous system effects, are known to be cardiotoxic. decline in overall CVD mortality rates (Table).

Cardiovascular Disease 40

Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease Cardiac Arrest 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP108-AWMP108, February 1, 2024. Introduction:There is strong evidence of an association between systemic inflammation and ischemic stroke. One measure of subclinical atherosclerosis, carotid artery intima-media thickness (CIMT), is independently associated with ischemic stroke.

Circulation 40

Circulation BMI Atherosclerosis Cerebrovascular Disease 40

DAIC

FEBRUARY 7, 2024

During the American Stroke Association’s International Stroke Conference 2024, ISC24, eleven scientists leading the way in stroke research will be recognized for their exceptional professional achievements. Sacco Outstanding Stroke Research Mentor Award, which honors Ralph L. 7-9 in Phoenix, AZ. 7-9 in Phoenix, AZ.

Stroke 105

Stroke Strokes Research Health Disparities 105

Dr. Smith's ECG Blog

APRIL 8, 2015

Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. to 3.80).

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52